logo
Sign InSign Up

DANAHER CORP (DHR)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for DHR, sign up here.

Income Statement

Revenue

$23.9bn

Gross Profit

$14.0bn

Earning before Tax

$5.6bn

Net Income

$4.8bn

Net Income Common Shareholders

$4.7bn

EPS

6.44

Balance Sheet

Cash

$5.9bn

Debt

$18.4bn

Assets

$84.5bn

Liabilities

$31.0bn

Equity

$53.5bn

Enterprise Value

$180.7bn

Cash Flow Statement

Net Cash from Operations

$7.2bn

Net Cash from Investing

$-7.1bn

Net Cash from Financing

$-0.3bn

Net Cash Flow

$-0.1bn

Free Cash Flow

$5.8bn

Free Cash Flow per Share

$7.87

Metrics

Price to Equity

36.04

Price to Equity (Damodaran)

35.92

Price to Book

3.20

Net Margin

0.20

Return on Equity

0.09

Return on Sales

0.25

Get immediate access to 5-years of reference grade data for DHR for free.

Sign up

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians'' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Company Info

Industry

Diagnostics & Research

Employees

63,000

Address

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States

Phone

202 828 0850

Last Updated

2024-02-08

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy